Julia Hamlin

Effect of omeprazole on the steady‐state pharmacokinetics of voriconazole

Nolan Wood, Keith Tan, Lynn Purkins et al. · British Journal of Clinical Pharmacology · 2003 · 105 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +9

Pharmacokinetics, safety and tolerability of a single oral dose of maraviroc in HIV-negative subjects with mild and moderate hepatic impairment

John D. Davis, Caroline E. Ridgway, Julia Hamlin et al. · Antiviral Therapy · 2008 · 59 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

Pharmacokinetic Interactions of Maraviroc with Darunavir-Ritonavir, Etravirine, and Etravirine-Darunavir-Ritonavir in Healthy Volunteers: Results of Two Drug Interaction Trials

Thomas N. Kakuda, John D. Davis, Julia Hamlin et al. · Antimicrobial Agents and Chemotherapy · 2011 · 36 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +13

Effects of Multiple Doses of Voriconazole on the Vision of Healthy Volunteers: A Double-Blind, Placebo-Controlled Study

Eberhart Zrenner, Konrad E. Tomaszewski, Julia Hamlin et al. · Ophthalmic Research · 2014 · 32 citations

Medicine, Ophthalmology, Pharmacology +12

Phase I trial involving the pharmacodynamic (PD) study of circulating tumour cells, of CP-751,871 (C), a monoclonal antibody against the insulin-like growth factor 1 receptor (IGF-1R), with docetaxel (D) in patients (p) with advanced cancer

Gerhardt Attard, Peter C.C. Fong, R. Molife et al. · Journal of Clinical Oncology · 2006 · 19 citations

Medicine, Pharmacology, Pharmacotherapy +15